Clinical Trial Update: Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of intravitreal injections of human retinal progenitor cells for Retinitis Pigmentosa, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• jCell intravitreal retinal progenitor cell therapy (retinal progenitor cells)

Snippet

Sponsor: jCyte, Inc | Conditions: Retinitis Pigmentosa | Phase 2 | Status: COMPLETED | Results posted: 2022-01-21